Literature DB >> 17425642

Type I and Type II error under random-effects misspecification in generalized linear mixed models.

Saskia Litière1, Ariel Alonso, Geert Molenberghs.   

Abstract

Generalized linear mixed models (GLMMs) have become a frequently used tool for the analysis of non-Gaussian longitudinal data. Estimation is based on maximum likelihood theory, which assumes that the underlying probability model is correctly specified. Recent research is showing that the results obtained from these models are not always robust against departures from the assumptions on which these models are based. In the present work we have used simulations with a logistic random-intercept model to study the impact of misspecifying the random-effects distribution on the type I and II errors of the tests for the mean structure in GLMMs. We found that the misspecification can either increase or decrease the power of the tests, depending on the shape of the underlying random-effects distribution, and it can considerably inflate the type I error rate. Additionally, we have found a theoretical result which states that whenever a subset of fixed-effects parameters, not included in the random-effects structure equals zero, the corresponding maximum likelihood estimator will consistently estimate zero. This implies that under certain conditions a significant effect could be considered as a reliable result, even if the random-effects distribution is misspecified.

Entities:  

Mesh:

Year:  2007        PMID: 17425642     DOI: 10.1111/j.1541-0420.2007.00782.x

Source DB:  PubMed          Journal:  Biometrics        ISSN: 0006-341X            Impact factor:   2.571


  28 in total

1.  Novel methods for the analysis of stepped wedge cluster randomized trials.

Authors:  Lee Kennedy-Shaffer; Victor de Gruttola; Marc Lipsitch
Journal:  Stat Med       Date:  2019-12-26       Impact factor: 2.373

2.  Nonlinear mixed-effects models for pharmacokinetic data analysis: assessment of the random-effects distribution.

Authors:  Reza Drikvandi
Journal:  J Pharmacokinet Pharmacodyn       Date:  2017-02-13       Impact factor: 2.745

3.  Prediction of random effects in linear and generalized linear models under model misspecification.

Authors:  Charles E McCulloch; John M Neuhaus
Journal:  Biometrics       Date:  2011-03       Impact factor: 2.571

4.  Reduced hierarchical models with application to estimating health effects of simultaneous exposure to multiple pollutants.

Authors:  Jennifer F Bobb; Francesca Dominici; Roger D Peng
Journal:  J R Stat Soc Ser C Appl Stat       Date:  2013-05       Impact factor: 1.864

5.  A note on type II error under random effects misspecification in generalized linear mixed models.

Authors:  John M Neuhaus; Charles E McCulloch; Ross Boylan
Journal:  Biometrics       Date:  2011-06       Impact factor: 2.571

6.  Linear mixed models for multiple outcomes using extended multivariate skew-t distributions.

Authors:  Binbing Yu; A James O'Malley; Pulak Ghosh
Journal:  Stat Interface       Date:  2014       Impact factor: 0.582

7.  A Semi-parametric Transformation Frailty Model for Semi-competing Risks Survival Data.

Authors:  Fei Jiang; Sebastien Haneuse
Journal:  Scand Stat Theory Appl       Date:  2016-08-31       Impact factor: 1.396

8.  Generalized Linear Mixed Models with Gaussian Mixture Random Effects: Inference and Application.

Authors:  Lanfeng Pan; Yehua Li; Kevin He; Yanming Li; Yi Li
Journal:  J Multivar Anal       Date:  2019-10-15       Impact factor: 1.473

9.  A nonstationary Markov transition model for computing the relative risk of dementia before death.

Authors:  Lei Yu; William S Griffith; Suzanne L Tyas; David A Snowdon; Richard J Kryscio
Journal:  Stat Med       Date:  2010-03-15       Impact factor: 2.373

10.  Cost Variation in Diabetes Care across Dutch Care Groups?

Authors:  Sigrid M Mohnen; Claudia C Molema; Wouter Steenbeek; Michael J van den Berg; Simone R de Bruin; Caroline A Baan; Jeroen N Struijs
Journal:  Health Serv Res       Date:  2016-03-21       Impact factor: 3.402

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.